The recent discovery of cancer cell-intrinsic surface-expressed programmed death ligand 1 (PDL1) signals to immune cell programmed death 1 (PD1) to inhibit antitumor immunity contributed to developing revolutionary immunotherapies. Here, CD274 is linked to cancer.